{"title":"Investigating Aortic Root Hemodynamics With EVAHEART2 Pump Speed Modulation.","authors":"Jasmine Martinez, Ruth White, Vikash Shukla, Benjamin Diaz, Kelsey Smegner, Shinji Kobayashi, Tadashi Motomura, Venkat Keshav Chivukula","doi":"10.1097/MAT.0000000000002577","DOIUrl":null,"url":null,"abstract":"<p><p>Left ventricular assist device (LVAD) therapy often reduces the chances of aortic valve opening (AVO), increasing the risk of blood stagnation and thrombus formation. The EVAHEART2 (EVA2) pump speed modulation (PSM) can be leveraged to mitigate these risks by encouraging AVO. Study aims to i) investigate how PSM impacts aortic root hemodynamics, ii) quantify how much transaortic valve flow is needed to washout the aortic root, and iii) evaluate how PSM may alter pulsatility in LVAD flow. Computational fluid dynamics simulations were used to quantify aortic root washout, washout progression, and perform platelet tracking to evaluate thrombogenic potential. Results showed that when the aortic valve (AV) was closed, only 60% of blood was washed out after 4 seconds, whereas AVO significantly increased washout efficiency, clearing over 80% of blood within 3 seconds. Platelet tracking revealed that platelets were up to 60% more likely to stagnate for a nonfunctional AV compared with transaortic flow scenarios. Higher transaortic flow had the lowest thrombogenic potential score. These findings demonstrate that transaortic valve flow is the primary factor driving aortic root washout. Using EVA2 PSM settings to enhance transaortic valve flow can improve aortic root washout. This study emphasizes the importance of strategies that enable LVAD patients to have a functional AV.</p>","PeriodicalId":8844,"journal":{"name":"ASAIO Journal","volume":" ","pages":"740-749"},"PeriodicalIF":2.2000,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ASAIO Journal","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1097/MAT.0000000000002577","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/10/15 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Left ventricular assist device (LVAD) therapy often reduces the chances of aortic valve opening (AVO), increasing the risk of blood stagnation and thrombus formation. The EVAHEART2 (EVA2) pump speed modulation (PSM) can be leveraged to mitigate these risks by encouraging AVO. Study aims to i) investigate how PSM impacts aortic root hemodynamics, ii) quantify how much transaortic valve flow is needed to washout the aortic root, and iii) evaluate how PSM may alter pulsatility in LVAD flow. Computational fluid dynamics simulations were used to quantify aortic root washout, washout progression, and perform platelet tracking to evaluate thrombogenic potential. Results showed that when the aortic valve (AV) was closed, only 60% of blood was washed out after 4 seconds, whereas AVO significantly increased washout efficiency, clearing over 80% of blood within 3 seconds. Platelet tracking revealed that platelets were up to 60% more likely to stagnate for a nonfunctional AV compared with transaortic flow scenarios. Higher transaortic flow had the lowest thrombogenic potential score. These findings demonstrate that transaortic valve flow is the primary factor driving aortic root washout. Using EVA2 PSM settings to enhance transaortic valve flow can improve aortic root washout. This study emphasizes the importance of strategies that enable LVAD patients to have a functional AV.
期刊介绍:
ASAIO Journal is in the forefront of artificial organ research and development. On the cutting edge of innovative technology, it features peer-reviewed articles of the highest quality that describe research, development, the most recent advances in the design of artificial organ devices and findings from initial testing. Bimonthly, the ASAIO Journal features state-of-the-art investigations, laboratory and clinical trials, and discussions and opinions from experts around the world.
The official publication of the American Society for Artificial Internal Organs.